JAC Advance Access originally published online on December 19, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Journal of Antimicrobial Chemotherapy (2004) 53, 217-224
© 2004 The British Society for Antimicrobial Chemotherapy
Drug resistance genes and trailing growth in Candida albicans isolates
Mycotic Diseases Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road, N.E., Mailstop G-11, Atlanta, Georgia 30333, USA
Received 17 June 2003; returned 1 August 2003; revised 10 October 2003; accepted 29 October 2003
Objectives: To investigate possible molecular mechanisms of azole resistance among fluconazole-susceptible bloodstream isolates of Candida albicans that displayed the trailing growth phenomenon, and to compare these isolates with bloodstream and mucosal isolates that showed reduced susceptibilities to fluconazole.
Methods: Twelve C. albicans isolates—seven trailing and five susceptible dose dependent (SDD) or resistant (R)—were screened for ERG11 mutations by DNA sequencing and quantification of ERG11, CDR1 and MDR1 expression by RT-PCR using the LightCycler high-speed PCR system.
Results: SDD and R isolates possessed more homozygous ERG11 mutations than did the trailing isolates. Two of these, V404I and V509M, have not been described previously and were found exclusively in fluconazole SDD and R isolates. Quantification of ERG11 expression revealed that both trailing and SDD and R isolates were capable of ERG11 up-regulation in response to fluconazole, although the SDD and R isolates showed maximal up-regulation at higher fluconazole concentrations. Quantification of CDR1 and MDR1 revealed that all isolates, regardless of in vitro fluconazole response, were capable of CDR1 and MDR1 up-regulation following fluconazole exposure. Furthermore, the SDD and R isolates expressed higher constitutive levels of CDR1 and MDR1 or CDR1, respectively, in the absence of drug compared with trailing isolates.
Conclusions: Trailing isolates, although susceptible to fluconazole, express the same molecular mechanisms as SDD and R isolates following fluconazole exposure but regulate them differently.
Keywords: C. albicans, azole drug resistance, molecular mechanisms
Present address. Department of Laboratory Medicine, Chung-Ang University College of Medicine, Seoul, South Korea;
* Corresponding author. Tel: +1-404-639-4041; Fax: +1-404-639-3546; E-mail: BSkaggs{at}cdc.gov
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  D. Agrawal, T. F. Patterson, M. G. Rinaldi, and S. G. Revankar Trailing end-point phenotype of Candida spp. in antifungal susceptibility testing to fluconazole is eliminated by altering incubation temperature J. Med. Microbiol., July 1, 2007; 56(7): 1003 - 1004. [Full Text] [PDF]
|
|
|
|
|
|
J.-S. Wang, S.-Y. Li, Y.-L. Yang, H.-H. Chou, and H.-J. Lo Association between fluconazole susceptibility and genetic relatedness among Candida tropicalis isolates in Taiwan J. Med. Microbiol., May 1, 2007; 56(5): 650 - 653. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Niimi, K. Maki, F. Ikeda, A. R. Holmes, E. Lamping, M. Niimi, B. C. Monk, and R. D. Cannon Overexpression of Candida albicans CDR1, CDR2, or MDR1 Does Not Produce Significant Changes in Echinocandin Susceptibility Antimicrob. Agents Chemother., April 1, 2006; 50(4): 1148 - 1155. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Espy, J. R. Uhl, L. M. Sloan, S. P. Buckwalter, M. F. Jones, E. A. Vetter, J. D. C. Yao, N. L. Wengenack, J. E. Rosenblatt, F. R. Cockerill III, et al. Real-Time PCR in Clinical Microbiology: Applications for Routine Laboratory Testing Clin. Microbiol. Rev., January 1, 2006; 19(1): 165 - 256. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K.-W. Chen, H.-J. Lo, Y.-H. Lin, and S.-Y. Li Comparison of four molecular typing methods to assess genetic relatedness of Candida albicans clinical isolates in Taiwan J. Med. Microbiol., March 1, 2005; 54(3): 249 - 258. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. F. Weldhagen Rapid Detection and Sequence-Specific Differentiation of Extended-Spectrum {beta}-Lactamase GES-2 from Pseudomonas aeruginosa by Use of a Real-Time PCR Assay Antimicrob. Agents Chemother., October 1, 2004; 48(10): 4059 - 4062. [Abstract] [Full Text] [PDF]
|
|